Skip to main content
AI Market Summary
Loading market intelligence...

Ortho Clinical Diagnostics Holdings plc (OCDX) Stock Forecast 2025 - AI Price Prediction & Analysis


Ortho Clinical Diagnostics Holdings plc (OCDX) AI Stock Price Forecast & Investment Analysis

Ortho Clinical Diagnostics Holdings plc Stock Price Chart and Technical Analysis

Loading Ortho Clinical Diagnostics Holdings plc interactive price chart and technical analysis...

Ortho Clinical Diagnostics Holdings plc (OCDX) - Comprehensive Stock Analysis & Investment Research

Deep dive into Ortho Clinical Diagnostics Holdings plc's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Ortho Clinical Diagnostics Holdings plc, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Ortho Clinical Diagnostics Holdings plc: Ortho Clinical Diagnostics Holdings plc operates in the Manufacturing sector, establishing it as a mid-cap growth opportunity.

Ortho Clinical Diagnostics Holdings plc (Stock Symbol: OCDX) is a leading company in the Manufacturing sector , specifically operating within the Surgical and Medical Instrument Manufacturing industry.

The organization employs approximately 4500 professionals worldwide .

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Ortho Clinical Diagnostics Holdings plc's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Ortho Clinical Diagnostics Holdings plc: With $2036M in annual revenue and 0.0% net margin, the company demonstrates developing profitability.

Annual Revenue: $2036 million generating a 0.0% net profit margin .

Market Capitalization: $4178 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Return on Equity (ROE): -0.1% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Ortho Clinical Diagnostics Holdings plc stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Ortho Clinical Diagnostics Holdings plc: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Ortho Clinical Diagnostics Holdings plc stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Ortho Clinical Diagnostics Holdings plc's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Ortho Clinical Diagnostics Holdings plc: Strong free cash flow generation demonstrates solid operational efficiency.

Ortho Clinical Diagnostics Holdings plc strategically competes in the highly dynamic Surgical and Medical Instrument Manufacturing marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

The company demonstrates robust operational efficiency through strong free cash flow generation of $221 million annually, complemented by impressive -67.8% year-over-year cash flow growth.

The company maintains a healthy 50.5% gross margin, indicating strong pricing power and operational efficiency.

Ortho Clinical Diagnostics Holdings plc (OCDX) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Ortho Clinical Diagnostics Holdings plc stock analysis.

Loading Ortho Clinical Diagnostics Holdings plc comprehensive fundamental analysis and insider trading data...

Deep dive into Ortho Clinical Diagnostics Holdings plc's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Ortho Clinical Diagnostics Holdings plc stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Ortho Clinical Diagnostics Holdings plc: With a P/E ratio of 1763.00, the market highly values future growth prospects.

P/E Ratio 1763.00x
P/B Ratio 9.48x
Market Cap $4178M
EPS $0.01
Book Value/Share $1.86
Revenue/Share $8.59
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Ortho Clinical Diagnostics Holdings plc converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Ortho Clinical Diagnostics Holdings plc: An ROE of -0.1% indicates room for improvement in shareholder value creation.

ROE -0.1%
ROA 0.0%
ROIC 2.2%
Gross Margin 50.5%
Operating Margin 10.3%
Net Margin 0.0%
EBT Margin 1.4%
Tax Rate 101.4%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Ortho Clinical Diagnostics Holdings plc's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Ortho Clinical Diagnostics Holdings plc: A current ratio of 1.89 shows adequate liquidity.

Current Ratio 1.89x
Quick Ratio 1.00x
D/E Ratio 4.91x
Financial Leverage 7.48x
Interest Coverage 1.3x
Working Capital $231M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Ortho Clinical Diagnostics Holdings plc's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Ortho Clinical Diagnostics Holdings plc: Free cash flow of $221M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $293M
Free Cash Flow $221M
Capital Spending $-72M
OCF Growth YoY -67.8%
FCF Growth YoY -97.3%
FCF/Sales 10.8%
CapEx/Sales 3.5%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Ortho Clinical Diagnostics Holdings plc uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Ortho Clinical Diagnostics Holdings plc: An asset turnover of 0.60x suggests room for improvement in asset utilization.

Asset Turnover 0.60x
Receivables Turnover 7.2x
Inventory Turnover 3.3x
Fixed Assets Turnover 2.6x
Days Sales Outstanding 51 days
Days Inventory 110 days
Payables Period 54 days
Cash Conversion Cycle 106 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Ortho Clinical Diagnostics Holdings plc's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Ortho Clinical Diagnostics Holdings plc: With annual revenue of $2036M, Ortho Clinical Diagnostics Holdings plc operates at significant scale.

Income Statement ($ Millions)
Total Revenue $2036M
Operating Income $210M
R&D Expense $6M
SG&A Expense $27M
Cost of Goods Sold $50M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 30%
Cash & Short-term Investments 8%
Total Liabilities 87%
Short-term Debt 2%
Accounts Receivable 7%
Inventory 10%
Dividend & Shareholder Information
Shares Outstanding 237M

Latest Ortho Clinical Diagnostics Holdings plc Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Ortho Clinical Diagnostics Holdings plc (OCDX) stock price and investment outlook.

, source: Reuters

Wall Street's main indexes rose for a third straight session on Thursday after early data suggested that the Omicron variant of the coronavirus was less severe than feared, lifting the mood ahead of ...

, source: Benzinga.com

Who is Carlyle Holdings II L.L.C.? Carlyle Holdings II L.L.C. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies ...

, source: Benzinga.com

Carlyle Partners VI Cayman Holdings, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ...

, source: Insider Monkey

Technology stocks had a lousy start to 2022. QQQ lost 9% of its value in January. Pandemic winners are getting crushed while energy stocks are surging.

Ortho Clinical Diagnostics Holdings plc Competitors & Peer Analysis - Manufacturing Sector

Comparative analysis of Ortho Clinical Diagnostics Holdings plc against industry peers and competitors in the Manufacturing sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio

Frequently Asked Questions - Ortho Clinical Diagnostics Holdings plc Stock Forecast

How accurate are Ortho Clinical Diagnostics Holdings plc stock predictions?

Our AI model shows a 8500% Spearman correlation coefficient for OCDX predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Ortho Clinical Diagnostics Holdings plc stock price forecasts?

Our analysis considers Ortho Clinical Diagnostics Holdings plc's financial metrics, Manufacturing sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Ortho Clinical Diagnostics Holdings plc a good investment in 2025?

Based on our AI analysis, Ortho Clinical Diagnostics Holdings plc shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Ortho Clinical Diagnostics Holdings plc forecasts updated?

Ortho Clinical Diagnostics Holdings plc stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Ortho Clinical Diagnostics Holdings plc Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Ortho Clinical Diagnostics Holdings plc stock.

My Portfolio

Investment Dashboard

Loading your portfolio...